# Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

> **NCT00404937** · PHASE3 · WITHDRAWN · sponsor: **Alcon Research**

## Conditions studied

- Post-surgical Inflammation

## Interventions

- **DRUG:** Tobradex (Antibiotic steroid combination)

## Key facts

- **NCT ID:** NCT00404937
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-12
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404937, "Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00404937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*